Mechanisms of resveratrol-induced platelet apoptosis

Cardiovascular Research

Volumn 83, Issue 3, 2009, Pages 575-585

  Lin, Kuan H ^a   Hsiao, George ^a   Shih, Chwen M ^a   Chou, Duen S ^a   Sheu, Joen R ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caspases; Cytochrome c; Mitochondria; Platelet apoptosis; Resveratrol

Indexed keywords

ACTIN; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 9; CENTRAL STIMULANT AGENT; CYTOCHROME C; GELSOLIN; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN BAX; PROTEIN BID; RESVERATROL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE LIFESPAN;

ACTINS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOOD PLATELETS; CASPASE 3; CASPASE 8; CASPASE 9; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; GELSOLIN; HUMANS; HYDROXYL RADICAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OLIGOPEPTIDES; P-SELECTIN; PHOSPHATIDYLSERINES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STILBENES; TIME FACTORS;

EID: 67651115784     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp139     Document Type: Article

References (34)

1. George JN. Platelets. Lancet 2000;355:1531-1539.
2. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C et al. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003;305:9-16.
3. Mills JC, Stone NL, Pittman RN. Extranuclear apoptosis. The role of the cytoplasm in the execution phase. J Cell Biol 1999;146:703-708.
4. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407: 802-809.
5. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1:19-30.
6. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003;43:857-866.
7. Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombintriggered platelet apoptosis. J Thromb Haemost 2006;4:2656-2663.
8. Leytin V, Allen DJ, Mykhaylov S, Mis L, Lyubimov EV, Garvey B et al. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun 2004;320:303-310.
9. Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005;25:467-471.
10. Dale GL, Friese P. Bax activators potentiate coated-platelet formation. J Thromb Haemost 2006;4:2664-2669.
11. Zhang H, Nimmer PM, Tahir SK, Chen J, Fryer RM, Hahn KR et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007;14:943-951.
12. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128:1173-1186.
13. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
14. Stef G, Csiszar A, Lerea K, Ungvari Z, Veress G. Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J Cardiovasc Pharmacol 2006;48:1-5.
15. Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS et al. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol 2007;139:475-485.
16. Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003;43:526-535.
17. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, Wiley S et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 2003;21:281-286.
18. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999;93:4222-4231.
19. Chou DS, Hsiao G, Shen MY, Tsai YJ, Chen TF, Sheu JR. ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets. Free Radic Biol Med 2005;39:237-248.
20. Baker GR, Sullam PM, Levin J. A simple, fluorescent method to internally label platelets suitable for physiological measurements. Am J Hematol 1997;56:17-25.
21. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278:294-298.
22. Portess DI, Bauer G, Hill MA, O'Neill P. Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 2007;67:1246- 1253.
23. Breitschopf K, Zeiher AM, Dimmeler S. Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem 2000;275:21648-21652.
24. Pradhan S, Genebriera J, Denning WL, Felix K, Elmets CA, Timares L. CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses. J Immunol 2006;177: 5956-5967.
25. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ 2001;8:551-563.
26. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87:4925-4936.
27. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005; 11:725-730.
28. Khosravi-Far R, Esposti MD. Death receptor signals to mitochondria. Cancer Biol Ther 2004;3:1051-1057.
29. Delmas D, Rebe C, Micheau O, Athias A, Gambert P, Grazide S et al. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004;23:8979-8986.
30. Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM et al. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Invest Ophthalmol Vis Sci 2006;47:3708-3716.
31. Plenchette S, Moutet M, Benguella M, N'Gondara JP, Guigner F, Coffe C et al. Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion. Leukemia 2001;15:1572-1581.
32. Piguet PF, Vesin C, Da Kan C. Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine 2002;18:222-230.
33. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003;42:423-438.
34. Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF et al. Oxidative signaling pathway for externalization of asma membrane phosphatidylserine during apoptosis. FEBS Lett 2000;477:1-7.